Company Search:
Advanced Search
Sponsored Links
Codexis, Incorporation Company Snapshot
Codexis, Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Codexis, Incorporation with three other companies in this sector in UNITED STATES : Personalis Inc (2019 sales of $65.21 million of which 100% was Medical Service), Blueprint Medicines Corp ($66.51 million of which 100% was Biopharmaceutical), and Luna Innovations Incorporated ($70.52 million of which 63% was Products and licensing).

Sales Analysis. Codexis, Incorporation reported sales of $68.46 million for the year ending December of 2019. This represents an increase of 13.0% versus 2018, when the company's sales were $60.59 million. Sales at Codexis, Incorporation have increased during each of the previous five years (and since 2014, sales have increased a total of 94%). Sales of Performance Enzymes saw an increase of 23.5% in 2019, from $47.07 million to $58.16 million. Not all segments of Codexis, Incorporation experienced an increase in sales in 2019: sales of Novel Biotherapeutics fell 23.8% to $10.30 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Codexis, Incorporation
  Stock Performance Chart for Codexis, Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 10.31
(Figures in U.S. Dollars)
1 Week 14.8%   13 Weeks -11.5%  
4 Weeks -39.6%   52 Weeks -49.8%  
Codexis, Incorporation Key Data:
  Ticker: CDXS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 68,458,000
(Year Ending Jan 2020).
Employees: 161
  Currency: U.S. Dollars Market Cap: 607,021,870
  Fiscal Yr Ends: December Shares Outstanding: 58,877,000
  Share Type: Common Closely Held Shares: 2,062,035
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.